Qiagen NV- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于公司

公司简介

公司代码QGEN

公司名称Qiagen NV

上市日期Sep 01, 1996

CEOMr. Thierry Bernard

员工数量5765

证券类型Ordinary Share

年结日Sep 01

公司地址Hulsterweg 82

城市VENLO

上市交易所NYSE Consolidated

国家Netherlands

邮编5912 PL

电话31773556600

网址https://www.qiagen.com/

公司代码QGEN

上市日期Sep 01, 1996

CEOMr. Thierry Bernard

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Roland Sackers

Managing Director, Chief Financial Officer, Member of the Executive Board

383.09K

+59.93%

Mr. Thierry Bernard

Chief Executive Officer, Managing Director, Member of the Executive Board

312.13K

+75.76%

Dr. Metin Colpan, Ph.D.

Independent Member of the Supervisory Board

171.79K

-57.00%

Tallett (Elizabeth E)

Independent Member of the Supervisory Board

47.22K

+10.37%

Prof. Dr. Ross L. Levine, M.D.

Independent Member of the Supervisory Board

16.27K

+30.83%

Prof. Dr. Elaine R. Mardis, Ph.D.

Independent Member of the Supervisory Board

3.97K

--

Mr. Stephen H. (Steve) Rusckowski

Independent Chairman of the Supervisory Board

24.00

--

Ms. Eva van Pelt

Independent Member of the Supervisory Board

--

Dr. Toralf Haag, Ph.D.

Independent Member of the Supervisory Board

--

Mr. Bert van Meurs

Independent Member of the Supervisory Board

--

名称

名称/职务

职务

持股

持股变动

Mr. Roland Sackers

Managing Director, Chief Financial Officer, Member of the Executive Board

383.09K

+59.93%

Mr. Thierry Bernard

Chief Executive Officer, Managing Director, Member of the Executive Board

312.13K

+75.76%

Dr. Metin Colpan, Ph.D.

Independent Member of the Supervisory Board

171.79K

-57.00%

Tallett (Elizabeth E)

Independent Member of the Supervisory Board

47.22K

+10.37%

Prof. Dr. Ross L. Levine, M.D.

Independent Member of the Supervisory Board

16.27K

+30.83%

Prof. Dr. Elaine R. Mardis, Ph.D.

Independent Member of the Supervisory Board

3.97K

--

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

业务USD

名称

营收

占比

Consumables and Related Revenues

435.06M

89.99%

Instrumentation

48.39M

10.01%

地区USD

名称

营收

占比

United States

232.85M

48.16%

Europe & Middle East & Africa

160.64M

33.23%

Asia, Pacific & Rest of the World

68.83M

14.24%

Other Americas

21.13M

4.37%

业务

地区

业务USD

名称

营收

占比

Consumables and Related Revenues

435.06M

89.99%

Instrumentation

48.39M

10.01%

股东统计

更新时间: 9月11日周四

持股股东

股东类型

持股股东

占比

Wellington Management Company, LLP

12.00%

MFS Investment Management

10.83%

BlackRock Institutional Trust Company, N.A.

9.47%

The Vanguard Group, Inc.

4.22%

T. Rowe Price International Ltd

2.74%

其他

60.74%

持股股东

占比

Wellington Management Company, LLP

12.00%

MFS Investment Management

10.83%

BlackRock Institutional Trust Company, N.A.

9.47%

The Vanguard Group, Inc.

4.22%

T. Rowe Price International Ltd

2.74%

其他

60.74%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

47.08%

Investment Advisor

32.87%

Research Firm

4.24%

Sovereign Wealth Fund

1.64%

Pension Fund

1.60%

Hedge Fund

1.43%

Holding Company

1.17%

Bank and Trust

1.02%

Individual Investor

0.44%

其他

8.50%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

996

189.55M

87.53%

+6.64M

2025Q1

1017

179.03M

82.67%

+27.58M

2024Q4

1010

129.03M

59.70%

-70.06M

2024Q3

1010

183.22M

84.72%

-23.62M

2024Q2

1002

184.34M

84.75%

+8.40M

2024Q1

988

165.20M

76.61%

-7.18M

2023Q4

993

165.11M

76.72%

-10.52M

2023Q3

987

159.93M

74.32%

-12.21M

2023Q2

996

162.43M

75.49%

-6.05M

2023Q1

1001

160.07M

74.44%

-9.45M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Wellington Management Company, LLP

24.44M

11.29%

+1.15M

+4.92%

Mar 31, 2025

MFS Investment Management

24.26M

11.2%

+24.26M

--

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

20.17M

9.31%

-350.47K

-1.71%

Jun 16, 2025

The Vanguard Group, Inc.

8.78M

4.06%

+245.16K

+2.87%

Mar 31, 2025

T. Rowe Price International Ltd

4.15M

1.92%

+4.01M

+2888.12%

Mar 31, 2025

EARNEST Partners, LLC

3.81M

1.76%

+3.81M

--

Mar 31, 2025

Amundi Asset Management, SAS

4.19M

1.94%

-516.05K

-10.96%

Mar 31, 2025

Swedbank Robur Fonder AB

3.06M

1.41%

+186.76K

+6.51%

May 31, 2025

Norges Bank Investment Management (NBIM)

3.96M

1.83%

-111.67K

-2.74%

Dec 31, 2024

持股ETF

更新时间: 9月6日周六

机构名称

占比

ROBO Global Healthcare Technology & Innovation ETF

1.62%

Zacks Small/Mid Cap ETF

0.71%

Fidelity International Multifactor ETF

0.4%

iShares ESG Advanced MSCI EAFE ETF

0.12%

iShares MSCI World ETF

0.01%

iShares Russell 2500 ETF

0%

SPDR MSCI EAFE StrategicFactors ETF

0%

iShares MSCI ACWI ex U.S. ETF

0%

Vanguard ESG International Stock ETF

0%

Global X Genomics & Biotechnology ETF

0%

ROBO Global Healthcare Technology & Innovation ETF

占比1.62%

Zacks Small/Mid Cap ETF

占比0.71%

Fidelity International Multifactor ETF

占比0.4%

iShares ESG Advanced MSCI EAFE ETF

占比0.12%

iShares MSCI World ETF

占比0.01%

iShares Russell 2500 ETF

占比0%

SPDR MSCI EAFE StrategicFactors ETF

占比0%

iShares MSCI ACWI ex U.S. ETF

占比0%

Vanguard ESG International Stock ETF

占比0%

Global X Genomics & Biotechnology ETF

占比0%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

公告日期

类型

比率

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 17, 2025

Merger

36→35

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

Jan 18, 2024

Merger

25→24.25

Qiagen NV

43.900USD

Qiagen NV

43.900

概览

公司

财务

分析